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Abstract
Immunohistochemical staining of tissues is a powerful tool used to delineate the presence or absence of an antigen. During
the last 30 years, antigen visualization in human brain tissue has been significantly limited by the masking effect of fixatives.
In the present study, we have used a new method for antigen retrieval in formalin-fixed human brain tissue and examined
the effectiveness of this protocol to reveal masked antigens in tissues with both short and long formalin fixation times. This
new method, which is based on the use of citraconic acid, has not been previously utilized in brain tissue although it has
been employed in various other tissues such as tonsil, ovary, skin, lymph node, stomach, breast, colon, lung and thymus.
Thus, we reported here a novel method to carry out immunohistochemical studies in free-floating human brain sections.
Since fixation of brain tissue specimens in formaldehyde is a commonly method used in brain banks, this new antigen
retrieval method could facilitate immunohistochemical studies of brains with prolonged formalin fixation times.
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Introduction
Immunohistochemicalstainingoftissuesisapowerful toolusedto
delineate the presence or absence of an antigen. During the last 30
years, antigen visualization in the human brain tissue has been
significantly limited by the masking effect of fixatives such as
formaldehyde, which is widely used and prepared from a
commercial concentrated formalin (40% solution of formaldehyde)
that is diluted to a 10% solution (10% formalin) [1]. Briefly, the
process of fixation implies the denaturalization of a biological
molecule, specifically changing its shape, which enables the
molecule to withstand the rigors of the tissue processing by locking
the secondary structure [2] and preventing the degradation of this
molecule by way of endogenous or microbial enzymes [3].
Formalin-fixed tissue is routinely used in pathology specimens
and gives excellent morphology. Therefore, such tissue is preferred
for immunohistochemical staining. The antigen masking effect of
the formalin fixation process has required the use of antigen
retrieval protocols before immunohistochemical staining. Since the
early 1990s, several procedures for antigen retrieval (AR) have
been developed and proven to be effective for immunohistochem-
istry on light microscopic preparations in human brain tissue [4].
These techniques are based on the immersion of the sections in
various solutions with different pH and at high temperatures for
variable times, in order to expose the highest number of antigenic
epitopes [5]. The effect of heating is probably the single most
important factor for AR [1,6–9], although other factors, such as
the pH of the solutions, are also important [10,11].
A commonly used technique for AR in brain tissue from various
animal sources before immunohistochemical or histochemical
staining is the heating in citrate buffer, pH 6.0 for times that range
from 20 to 40 minutes [12]. This procedure has been demon-
strated to be valid for AR in human brains fixed in 4%
paraformaldehyde for a short period of time [13]. However, it
does not work well enough in tissue fixed and stored for long
periods in formaldehyde. It is known that the duration of formalin
fixation is crucial to the retention of antigen expression [14] but,
unfortunately, fixation time is not closely controlled routinely and
sections are often fixed for much longer times than desired.
Improved methods for AR in tissues subjected to prolonged
fixation in formalin are, therefore, needed for optimal immuno-
histochemical and histochemical staining.
In the present study, we describe a new method for AR in
formalin-fixed human brain tissue and examined the effectiveness
of this protocol to reveal masked antigens in tissues with both short
and long formalin fixation times. This new method, which is based
on citraconic acid, has not been previously used in brain tissue
although it has been employed in various other tissues such as
tonsil, ovary, skin, lymph node, stomach, breast, colon, lung and
thymus.
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In developing this new AR method, we have used seven human
brains from individuals of both sexes (two males and five females),
fixed and stored in formaldehyde for variable periods of time,
ranging from 10 days to 7 years (Table 1). Four human brains
were provided by the Brain Bank of the Neuropathology
Laboratory of the Hospital de Alcorco ´n (Madrid, Spain) and
the Alzheimer’s disease and Schizophrenia Brain Bank of the
Mount Sinai Hospital (New York City, USA), with the
corresponding written consents given by the patients or their
relatives. Three human brains were provided by the Department
of Pathology of the Hospital Ramo ´n y Cajal (Madrid, Spain); at
the time of the decease, the relatives of these patients were asked
for authorization to perform the medical autopsy. Then, many
medical samples were anonymized and kept in the hospital for
research purposes. The biological samples of the present study
were provided by these Departments after the approval of our
specific project by the corresponding Ethical Committees of the
hospitals where the samples were taken (Hospital de Alcorco ´n,
Hospital Ramo ´n y Cajal and Mount Sinai Hospital) and the
Universidad Auto ´noma de Madrid.
The slabs received were cut on a freezing microtome into 50-
mm-thick coronal sections. All sections were collected with a
paintbrush moistened in 0.01 M phosphate buffer (PB), pH 7.4,
and stored in a cryoprotectant solution containing ethylene
glycol (30%), and glycerol (30%) in 0.05 M PB. Series of free-
floating sections were then immunohistochemically processed to
visualize calbindin D-28K (CB), substance P (SP), glutamic acid
decarboxilase (GAD 65&67), tyrosine hydroxylase (TH) and
enkephalin (ENK). All stained sections were mounted on
gelatine-coated slides, dehydrated, cleared in xylene, and cover-
slipped with Depex.
Immunohistochemistry
Briefly, after a 0.1 M PB and 0.2% Triton X-100 rinse cycle of
three ten minutes rinses, the slices were immersed in a Petri dishes
(60 mm615 mm) sealed with ParafilmH and shaken for 45 min-
utes in a 0.05% citraconic anhydride solution (volume for each
Petri dish: 3 ml; pH 7.4) at 95uC (ImmunoSaver Antigen
Retriever, Electron Microscopic Sciences, Hatfield, PA) in a water
bath with shaking device (Memmert, Schwabach, Germany). In
order to maintain the same conditions for all the slices used in the
experiment, the tissue does not be immersed in the citraconic
anhydride solution until the water bath reach the 95uC. The
sections went through the PB and Triton X-100 rinse cycle and
were then placed in a 50% ethanol (1:3) and 3% H2O2 (2:3)
solution for 30 minutes to inactivate endogenous peroxidase
activity. The sections went through a second PB and Triton X-
100 rinse cycle and were then preincubated for 90 minutes in a
solution containing 0.1 M PB and 0.5% Triton X-100, and 4% of
the appropriate normal serum. Then, the sections were incubated
in a solution containing 0.1 M PB and 0.5% Trito ´n X-100, the
primary antibody, and 4% of the appropriate normal serum
(Table 2). After another PB and Triton X-100 rinse cycle they
were incubated for 90 minutes at room temperature in a solution
containing 0.1 M PB and 0.3% Trito ´n X-100, the secondary
antibody (0.4%), which was always biotinylated IgG (Vector
Laboratories, Burlingame, CA), and with 2% of the appropriate
normal serum. The slices were again rinsed in the PB and Triton
X-100 rinse cycle before standard avidin-biotin complex methods
(ABC Standard Kit, Vector Laboratories) were applied with 3,3-
Table 1. Data of the human specimen used in this study.
Case Sex Age (years) Hemisphere
Postmortem
delay (hours)
Storage time in
formalin (10%) Weight (g) Cause of death
1 Male 72 Right Unknown 3 years 1215 Sepsis
2 Female 66 Right Unknown 4 years 1131 Myocardial infarct
3 Male 57 Left 3 17 days 1390 Hemorrhage
4 Female 80 Unknown 6.8 7 years 1049 Acute coronary thrombosis
5 Female 90 Unknown 7.7 7 years 1008 Septic shock
6 Female Unknown Left Unknown 6 months 1350 Unkown
7 Female 20 Left 2 10 days 1100 Myocardial infarct
doi:10.1371/journal.pone.0003378.t001
Table 2. Antibodies used in this study.
Primary antibody Laboratory* Animal source Dilution Time of incubation Time of DAB
CB Sigma Mouse 1:2500 Overnight / 4uC2 m i n
SP Medicorp Rat 1:50 Overnight / 4uC4 m i n
GAD Millipore Rabbit 1:1000 Overnight / 4uC3 m i n
TH Diasorin Mouse 1:250 Overnight / 4uC4 m i n
ENK Medicorp Mouse 1:50 48 h / 4uC5 m i n
*Sigma: St.Louis, MO, USA; Medicorp: Montreal, Canada; Millipore: Billerica, MA, USA; Diasorin Inc: Stillwater, MN, USA.
Abbreviations: CB, calbindin-D28k; DAB, 3,39-diaminobenzidine tetrahydrochloride; ENK, enkephalin; GAD, glutamic acid decarboxilase; SP, substance P; TH, tyrosine
hydroxylase.
doi:10.1371/journal.pone.0003378.t002
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MO) and, in some cases (GAD 65&67; CB D-28K and TH) the
reaction was intensified with Nickel Sulfate Hexahydrate (Sigma,
St. Louis, MO). Appropriate controls were also carried out in our
case material for the immunohistochemistry technique described
here; in all cases the first antibody was omitted in the protocol.
To determinate the optimal conditions of citraconic anhydrides
protocol (heating time, temperature and heat source), we first
performed a preliminary study in which different heating times
(ranging from 30 minutes to 60 minutes) as well as temperatures
(ranging from 85uCt o9 5 uC) and heat sources (water bath vs
microwave) were used in order to obtain the optimal procedure to
carry out immunohistochemical stainings in formaldehyde fixed
human brains. Once the optimal conditions to carry out
immunohistochemical procedures were established (45 minutes
in a 0.05% citraconic anhydride solution, pH 7.4, at 95uC),
formalin fixed brain tissue sections were subjected to the AR
method, obtained a similar intensity of immunostaining compared
to a protocol widely used in immunohistochemical studies [15]. In
the last protocol, it is not necessary to carry out any AR methods,
because the 0.5-cm-thick brain slabs were fixed in a solution
containing 4% paraformaldehyde in 0.125 M phosphate buffer,
pH 7.4 during a period of 10 days, then immersed in 15% sucrose
in PB at 4uC for 4–7 days in order to protect them before cutting.
The sucrose solution was renewed every 2 days. For long term
storage, the material was stored in PB with 15% sucrose and 0.1%
sodium azide at 4uC. From here on, the protocol employed was
the same as the one used in the formaldehyde slabs.
Sources of the antibodies
Table 2 summarizes the information on the antibodies used in
this study. The CB antibody was highly specific mouse monoclonal
(clon 300) [16,17]. The SP antibody was a rat monoclonal
antibody that does not cross-react with other known mammalian
brain peptides [18]. The GAD antibody reacts specifically with 65
and 67 isoforms. TH antibody is a mouse monoclonal antibody
isolated and purified from rat PC12 cells. The monoclonal
antibody used to visualize ENK does not distinguish between met-
enkephalin and leu-enkephalin [19].
SP is an undecapeptide widely distributed in the central nervous
system. It mediates its biological actions through the G-protein
coupled to the tachykinin receptor NK1 [15,20]. This neuropep-
tide plays a major role in arthritis, emesis, apoptosis, pain,
gastrointestinal and respiratory function and depressive and
anxiety disorders [15,20–22].
GAD is the only enzyme responsible for the irreversible
conversion of L-glutamic acid to GABA. There have been
identified two isoforms of GAD, designated GAD65 and GAD67,
accordingly with their molecular weights. As it is know, gamma-
aminobutyric acid (GABA) is the principal inhibitory neurotrans-
mitter in the mammalian central nervous system.
Regarding the TH, this enzyme converts L-tyrosine to 3,4-
dihydroxyphenylalanine (DOPA), in a pathway of catecholamines.
TH is present in adrenal medulla, brain and all sympathetically
innervated tissues.
Finally, ENK, is an endogenous opioid and an agonist at the m-
opioid receptor, involved in regulation of emotional memory,
thermal pain perception, stress-induced analgesia, saliency,
suppression of the affective qualities of a pain stressor and in the
regulation of mood and behaviour [15,23–29].
Illustration of the results and data analysis
The experimental material of this study was analyzed using the
Mai et al. atlas of the human brain (1997; 2002). The stained
sections were first examined with a Nikon Eclipse 80i microscope
(Nikon, Melville, NY) at 206 magnification. Microphotographs
were taken with a Nikon DXM1200F digital microscope camera
at 300 ppi or higher resolution and saved in TIFF format.
Photographic brightness and contrast were adjusted with Adobe
Photoshop (Adobe Systems, San Jose, CA) and Canvas (Deneba
Systems Inc., Miami, FL).
Nomenclature
In the thalamus, the boundaries of the nuclei in the present
study were delineated according to the nomenclature suggested by
Hirai and Jones [30] and Jones [31], which is derived from the
nomenclature of the thalamus in non-human primates [32,33].
Evaluation of immunostainings
Evaluation of immunohistochemical staining for the different
antibodies was done independently by four observers experienced
in immunohistochemical assessment in human brains (IIZ, MGA,
LPS and RAP). The intensity of immunostaining was judged as
weak, moderate or strong (fibers, soma and background). Only the
evaluations that were in agreement in three or more observers
were considered as final.
Results
To date, our study is the first to describe a protocol for AR that
allows optimal immunohistochemical staining for several antibod-
ies in the human brain tissue that have been fixed and stored in
formaldehyde for long periods. This AR method, which utilizes a
citraconic anhydride solution, has previously been shown to be
superior to conventional AR methods in various tissues (Citrate
buffer and Tris-HCL+5% urea) [34].
The immunostaining for CB in the mediodorsal thalamic
nucleus in the formaldehyde fixed brains showed less intense
staining of the neuropil than in the conventional immunostaining
method (Figure 1). We have found in the formaldehyde fixed slices
an enhancement in the intensity of CB-immunoreactive (-ir)
somata. With both methods, numerous short fibers without
varicosities were observed.
The anteroventral thalamic nucleus in the formaldehyde fixed
brains and in the conventional immunostaining method showed
many intense SP-ir fibers in a weakly stained neuropil. These fibers
present numerous round varicosities resembling button like
structures, but no SP-ir somata were seen (Figure 2).
The immunostaining for GAD 65&67 in the mediodorsal
thalamic nucleus in formaldehyde fixed brains showed a similar
staining intensity that the conventional immunostaining method
(Figure 3). We found weakly stained somas and intense fibers in a
moderately stained neuropil. There was no apparent effect on
morphology in the GAD-ir neurons, although in fomaldehyde
fixed sections it is difficult to distinguish processes. The distribution
of cells followed a heterogeneous pattern throughout its entire
extent, as it was also seen in tissue processed by the conventional
immunostaining method.
The immunostaining for TH in the substantia nigra in the
formaldehyde fixed brains showed an enhancement in the
intensity of staining compared to the conventional immuno-
staining method (Figure 4), with an apparent effect on the
morphology of these neurons (somas more preserved than in the
conventional immunostaining method and processes more
delineated), although we did not find differences in the pattern
of distribution of these cells. There were an abundant number of
intense stained fibers without varicosities in a weakly stained
Antigen Retrieval Technique
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conventional immunostaining method.
Finally, the immunostaining for ENK in the caudate nucleus in
the formaldehyde fixed brains revealed numerous fibers with
varicosities in a weakly stained neuropil, but no ENK-ir somata.
These fibers were better delineated than in the conventional
immunostaining method (Figure 5).
Discussion
Fixation of tissue specimens in formaldehyde is a commonly
used method in pathology laboratories and in brain banks, being
the principal source of human brain samples for research studies
(i.e. immunohistochemical studies in free-floating sections).
However, this method based on fixation in formaldehyde for a
long time does not allow an optimal localization and
accessibility of antigens to their specific antibodies. Several
AR methods have been developed to address this problem. The
variety of methods undoubtedly contributes to discrepancies
among the immunostaining results of different investigations
[34].
In the present study, we have investigated a new AR method to
optimize immunostaining in free-floating human brain sections,
showing that, heating formalin-fixed tissue in 0.05% citraconic
Figure 1. A, Immunohistochemistry for CB in the MD. High power view of some CB-ir neurons in the human mediodorsal thalamic nucleus
without the employ of citraconic anhydride solution. B, high power view of CB-ir neurons in the same nucleus employing the citraconic anhydride
solution. Note the enhancement in the intensity of CB-ir somata. Scale bar: 50 mm.
doi:10.1371/journal.pone.0003378.g001
Figure 2. A, Neuropeptide immunohistochemistry in the human thalamus. Bright field photomicrographs in high magnification of SP fibers
without citraconic anhydride solution in the anteroventral thalamic nucleus. B, bright field photomicrographs in high magnification of SP fibers with
citraconic anhydride solution in the same nucleus. Note the enhancement in the intensity of SP-ir fibers and in the number of fibers. Scale bar: 25 mm.
doi:10.1371/journal.pone.0003378.g002
Figure 3. A, Interneuron immunohistochemistry in the MD. High power view of some GAD-ir neurons in the mediodorsal thalamic nucleus
without the use of citraconic anhydride solution. B, high power view of a GAD-ir neuron in the mediodorsal thalamic nucleus utilizing the citraconic
anhydride solution. Scale bar: 25 mm.
doi:10.1371/journal.pone.0003378.g003
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immunostaining for several antigens.
Temperature has been considered one of the most important
variables for retrieval of antigens concealed by formalin fixation
[4,34]. Here, we have observed that a temperature of 95uCi s
optimal since it allowed us to retrieval antigens and does not
damage the tissue.
In addition, different heating methods have been used for AR,
such microwaving [4], autoclaving [6,35], pressure cooking [36],
steam heating [37] and water bath [7,34]. In our study, the latter
has been the one we have used because it allowed us to establish an
optimal control of the samples.
Different solutions to AR combined with heat has been
developed, all of then reviewed periodically [3]. The most
commonly used has been citrate buffer (pH 6.0) and the Tris-HCl
buffer containing 5% urea (pH 9.0) [34]. In a recent paper,
Namimatsu et al. [34] have proposed a new AR method based on
the use of citraconic anhydride, and they compared this protocol
with citrate buffer and Tris-HCl in paraffin-embedded sections of
different tissues, as tonsil, ovary, skin, lymph node, stomach, breast,
colon, lung and thymus [34]. This group concluded that the AR
method based on citraconic anhydride allowed them to carry out
optimal immunostaining procedures in comparison of the existing
AR protocols, so the extent and the intensity of immunostainings is
enhanced [34]. Moreover, this new AR method provides some
advantages, for instance the reliability, the possibility to establish as
a universal AR method, and the possibility to process the slices in
one batch [34].
Although Namimatsu et al. [34] have employed the citraconic
anhydride in several tissues, as far as we know nobody has tested
Figure 4. A–B, Immunohistochemistry for TH in the substantia nigra. High power view (106and 206magnification respectively) of TH-ir
neurons in the substantia nigra employing the citraconic anhydride solution. Note the enhancement in the intensity and morphology (somas more
preserved and processes more delineated) compared to the conventional immunostaining method (C–D). Scale bar: A and C 100 mm; B and D
50 mm.
doi:10.1371/journal.pone.0003378.g004
Figure 5. A, Immunohistochemistry for ENK in the caudate nucleus. Bright field photomicrographs in high magnification of ENK fibers
without citraconic anhydride solution in the caudate nucleus. B, bright field photomicrographs in high magnification of ENK fibers with citraconic
anhydride solution in the same nucleus. Note that the latter fibers are better delineated than in the conventional immunostaing method. Scale bar:
50 mm.
doi:10.1371/journal.pone.0003378.g005
Antigen Retrieval Technique
PLoS ONE | www.plosone.org 5 October 2008 | Volume 3 | Issue 10 | e3378this AR method in human brain sections for immunohistochem-
ical free-floating studies. When we did probes in human brain
tissue, our results confirmed that employing the citraconic
anhydride combined with heat as an AR method in human
brain sections allowed us to carry out optimal free-floating
immunohistochemistry procedures, independently of the fixation
time in formaldehyde.
We have tested five antibodies commonly used in neurochem-
ical human brain studies, specifically at subcortical levels
(anteroventral thalamic nucleus, mediodorsal thalamic nucleus,
substantia nigra and caudate nucleus). For example, the calcium-
binding protein calbindin, which is an excellent neurochemical
marker for the morphological study of the human thalamus and
its nuclear subdivisions [15,38–41] was successfully used in this
study (Figure 1; see Figures 2–5 for immunostainings of SP,
GAD, TH and ENK). Besides, it is interesting to note that the
methodology we have described in this study has been successful
in showing both projection neurons and interneurons in the
human thalamus [42].
The samples used in the present study had variable fixation
times, ranging from 10 days to 7 years (Table 1). As we said, it is a
fact well established that formaldehyde fixation compromises
immunoreactivity of some antigen, not usually by damaging or
removing the antigens but by preventing contact between
epitopes and antibodies. The way that tissue molecules are
modified affects the outcome of immunohistochemical staining
[3]. Basically the fixation process has three stages. Firstly, the
formaldehyde dissolves in water, combining with it to form
methylene hydrate (methylene glycol). Then, it can react with
almost all end groups found in biological molecules such as
amines, amides, hydroxyls, sufhydryls, reactive hydrogen atoms
from aromatic amino acids, etc; the aldehyde combination result
in the attachment of various hydroximethyl adducts at the
original end groups [43]. Finally, this addition is followed by
crosslinking with other end groups by the formation of a
methylene bridge -CH2- (Figure 6) [3].
The particular reaction of formaldehyde with proteins has been
studied extensively. The aldehyde group can react with some
atoms of proteins like nitrogen, oxygen, sulphur or carbon, etc.
[44]. A well-studied example of this reaction is the crosslink
between the nitrogen atom at the end of the side chain of lysine
and the nitrogen atom of a peptide linkage (Figure 6).
The fixation by formaldehyde is almost completed in 24 hours
but the formation of methylene bridges proceeds much more
slowly [45]. Formaldehyde also affects nucleic acids by forming
adducts with exocyclic nitrogen atoms in nucleotides [46]. This
immobilization of DNA and RNA is also attributed to trapping of
the long nucleic acid molecules in networks of associated basic
protein molecules, which are cross-linked by methylene bridges.
Other substances such as carbohydrates, lipids, and so on, are
trapped in a matrix of insolubilized and crosslinked protein
molecules but are not chemically changed by formaldehyde unless
fixation is prolonged for several weeks [44].
In summary, we have reported a novel method to carry out
immunohistochemical studies in free-floating human brain
sections. Because fixation of brain tissue specimens in formalde-
hyde is a commonly method used in brain banks, this new AR
method could facilitate immunohistochemical studies of brains
with prolonged formalin fixation.
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formation of methylene bridges between closed proteins.
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